Trials / Sponsors / ChemomAb Ltd.
ChemomAb Ltd.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic Sclerosis Systemic Sclerosis | Phase 2 | 2026-09-01 |
| Completed | CM-101 in NASH Patients - The SPLASH Study Nonalcoholic Steatohepatitis | Phase 2 | 2021-02-24 |
| Unknown | CM-101 in PSC Patients -The SPRING Study Primary Sclerosing Cholangitis | Phase 2 | 2020-10-01 |
| Completed | Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechani Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC), Systemic Sclerosis (SSc) | Phase 1 | 2019-03-05 |
| Completed | The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NA Nonalcoholic Fatty Liver Disease | Phase 1 | 2018-12-11 |
| Completed | Intravenous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanis Healthy | Phase 1 | 2017-07-24 |